Rohan Ghadi

Employment

• Dr Reddy's Laboratories Ltd Technical Trainee
  2016 - 2017

Education

• National Institute of Pharmaceutical Education and Research Ph. D
  2017 - Present
• National Institute of Pharmaceutical Education and Research Hyderabad M.S.(Pharm)
  2014 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• A bird's eye view of the advanced approaches and strategies for overshadowing triple negative breast cancer
  Journal of Controlled Release 2021 DOI: 10.1016/j.jconrel.2020.12.012
  +Save
• Green surfactant-dendrimer aggreplexes: An ingenious way to launch dual attack on arch-enemy cancer
  Colloids and Surfaces B: Biointerfaces 2021 DOI: 10.1016/j.colsurfb.2021.111821
  +Save
• Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy
  Materials Science and Engineering C 2021 DOI: 10.1016/j.msec.2020.111832
  +Save
• Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance
  International Journal of Pharmaceutics 2020 DOI: 10.1016/j.ijpharm.2020.119088
  +Save
• Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer to Overcome the Limitations of Systemic Chemotherapy
  Molecular Pharmaceutics 2020 DOI: 10.1021/acs.molpharmaceut.0c00211
  +Save
• Lipid and Biosurfactant Based Core-Shell-Type Nanocapsules Having High Drug Loading of Paclitaxel for Improved Breast Cancer Therapy
  ACS Biomaterials Science and Engineering 2020 DOI: 10.1021/acsbiomaterials.0c01290
  +Save
• Exploring an interesting dual functionality of anacardic acid for efficient paclitaxel delivery in breast cancer therapy
  Nanomedicine 2019 DOI: 10.2217/nnm-2018-0138
  +Save
• Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin
  International Journal of Pharmaceutics 2019 DOI: 10.1016/j.ijpharm.2019.02.013
  +Save
• BCS class IV drugs: Highly notorious candidates for formulation development
  Journal of Controlled Release 2017 DOI: 10.1016/j.jconrel.2017.01.014
  +Save
• Poly(lactic acid)-based nanocomposites
  Polymers for Advanced Technologies 2017 DOI: 10.1002/pat.3985
  +Save